Pleo Chrys (Sanum Kehlbeck GmbH & Co. KG)


Welcome to the PulseAid listing for the Pleo Chrys drug offered from Sanum Kehlbeck GmbH & Co. KG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Sanum Kehlbeck GmbH & Co. KG
NON-PROPRIETARY NAME: human placenta hydrolysate
SUBSTANCE NAME: HUMAN PLACENTA HYDROLYSATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2004-10-15
END MARKETING DATE: 0000-00-00


Pleo Chrys HUMAN OTC DRUG Details:

Item DescriptionPleo Chrys from Sanum Kehlbeck GmbH & Co. KG
LABELER NAME: Sanum Kehlbeck GmbH & Co. KG
DEA SCHEDULE:
ACTIVE STRENGTH: 5([hp_X]/2mL)
START MARKETING DATE: 2004-10-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60681-1086_cbf8a5ca-4a01-4d24-8224-822f91db8de6
PRODUCT NDC: 60681-1086
APPLICATION NUMBER:

Other HUMAN PLACENTA HYDROLYSATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sanum Kehlbeck GmbH & Co. KGPleo Chrys